Browsing by Author "Valenzuela, Rodrigo"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- ItemBeneficial Effects of Bioactive Compounds Obtained from Agro-Industrial By-Products on Obesity and Metabolic Syndrome Components(2022) Jeria, Nicolas; Cornejo, Sebastian; Prado, Gabriel; Bustamante, Andres; Garcia-Diaz, Diego F.; Jimenez, Paula; Valenzuela, Rodrigo; Poblete-Aro, Carlos; Echeverría González, Francisca CeciliaThe generation of agro-industrial by-products is an economic and environmental problem. However, these raw materials could be a suitable source for obtaining bioactive compounds for technological or nutritional purposes. On the other hand, obesity and metabolic syndrome prevalence are in continuous growth. The classical approach of hypocaloric diet and exercise has shown little long-term adherence. Thus, there is an unending search for new strategies to prevent and treat obesity and related metabolic alterations. In that sense, the revalorization of agro-industrial by-products for functional foods and nutraceutical development has gained relevance. Pomegranate, onion, and grape by-products, among others, have been described as promising raw materials for bioactive compounds obtention. Nevertheless, scientific evidence on the effects of specific sources and bioactive compounds on obesity models and clinical trials is needed. This article aims to show available data from studies on the effect of bioactive compounds obtained from agro-industrial by-products on obesity and metabolic syndrome components.
- ItemDietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics(2023) Farías, Camila; Cisternas, Camila; Gana Ansaldo, Juan Cristóbal; Alberti, Gigliola; Echeverría González, Francisca Cecilia; Videla, Luis A.; Mercado, Lorena; Muñoz, Yasna; Valenzuela, RodrigoNonalcoholic fatty liver disease (NAFLD) is pediatrics’ most common chronic liver disease. The incidence is high in children and adolescents with obesity, which is associated with an increased risk of disease progression. Currently, there is no effective drug therapy in pediatrics; therefore, lifestyle interventions remain the first line of treatment. This review aims to present an updated compilation of the scientific evidence for treating this pathology, including lifestyle modifications, such as exercise and dietary changes, highlighting specific nutritional strategies. The bibliographic review was carried out in different databases, including studies within the pediatric population where dietary and/or nutritional interventions were used to treat NAFLD. Main interventions include diets low in carbohydrates, free sugars, fructose, and lipids, in addition to healthy eating patterns and possible nutritional interventions with n-3 polyunsaturated fatty acids (EPA and DHA), amino acids (cysteine, L-carnitine), cysteamine, vitamins, and probiotics (one strain or multi-strain). Lifestyle changes remain the main recommendation for children with NAFLD. Nevertheless, more studies are required to elucidate the effectiveness of specific nutrients and bioactive compounds in this population.
- ItemN-3 PUFAs and their specialized pro-resolving lipid mediators on airway inflammatory response: beneficial effects in the prevention and treatment of respiratory diseases(2022) Zúñiga-Hernández, Jessica; Sambra, Verónica; Echeverría González, Francisca Cecilia; Videla, Luis A.; Valenzuela, RodrigoRespiratory diseases include a wide range of pathologies with different clinical manifestations, affecting the normal airways and lung function. An increase in the inflammatory response is considered a characteristic hallmark of these diseases, being also a critical factor for their progression. The n-3 polyunsaturated fatty acids (n-3 PUFAs) eicosapentaenoic acid (C20:4n-3, EPA), docosahexaenoic acid (C22:6n-3, DHA) and their lipid mediators are known to have an inflammation pro-resolution effect. The effects of these n-3 PUFAs in the prevention and treatment of respiratory diseases are beginning to be understood. Consequently, this article aims to analyze the influence of n-3 PUFAs and their lipid mediators on the inflammatory response in respiratory health, emphasizing recent data concerning their beneficial effects in the prevention and possible treatment of different respiratory diseases, particularly asthma, airway allergic syndromes and chronic obstructive pulmonary disease. The review includes studies regarding the effects of EPA, DHA, and their specialized pro-resolving lipid mediators (SPMs) on in vivo and in vitro models of respiratory disease, concluding that EPA and DHA have a positive impact in attenuating the pro-inflammatory response in respiratory diseases, reducing symptoms like nasal congestion, fever and difficulty in breathing. Controversial data reported are probably due to differences in several factors, including the dosages, administration vehicles, and the supplementation times employed, which are aspects that remain to be addressed in future studies.
- ItemPolyphenols in the Prevention and Treatment of Non-communicable Diseases(2022) Echeverría González, Francisca Cecilia; Valenzuela, Rodrigo
- ItemPotencial efecto terapéutico de los polifenoles obtenidos de la cáscara de granada en la esteatosis hepática(2022) Bustamante, Andres; Garcia-Diaz, Diego; Jimenez, Paula; Valenzuela, Rodrigo; Pando, Maria Elsa; Echeverría González, Francisca CeciliaAntecedentes: La enfermedad por hígado graso no alcohólico (EHGNA) tiene una elevada prevalencia a nivel mundial, y puede ir desde la esteatosis simple hasta hepatocarcinoma. Su origen es multifactorial, siendo la dieta poco saludable un factor clave en su patogenia y progresión. Los polifenoles son antioxidantes que han mostrado beneficios en el tratamiento de la EHGNA. Una fuente emergente de estos compuestos son los residuos agroindustriales, entre ellos, la cáscara de granada. La cáscara de granada tiene un alto contenido de polifenoles, específicamente de elagitaninos. Su extracto fenólico (extracto de cáscara de granada; ECG) ha mostrado efectos promisorios a nivel metabólico. Sin embargo, su uso presenta algunas limitantes que deben ser consideradas antes de recomendar su ingesta mediante alimentos funcionales o nutracéuticos para prevención o tratamiento de EHGNA. Objetivo: Discutir a partir de datos obtenidos en estudios in vitro y modelos animales, el potencial terapéutico de los polifenoles obtenidos de la cáscara de granada para prevención y tratamiento de la EHGNA. Metodología: Se realizó una búsqueda bibliográfica en bases de datos PubMed y Web of Science (2015 a la fecha) de estudios en modelos de esteatosis hepática in vitro y en animales, además de ensayos clínicos relacionados. Conclusión: Existen datos promisorios sobre el uso del ECG en alteraciones metabólicas propias de la EHGNA y esteatosis hepática, principalmente a nivel de perfil lipídico. Se deben discutir las dosis y formas de administración, con el fin de mejorar su estabilidad y biodisponibilidad. Se requieren ensayos clínicos controlados que confirmen los efectos en humanos.